3.3(top 10%)
impact factor
645(top 20%)
papers
16.9K(top 10%)
citations
62(top 10%)
h-index
3.4(top 10%)
impact factor
751
all documents
18.0K
doc citations
94(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Acute Lung Injury: Epidemiology, Pathogenesis, and TreatmentJournal of Aerosol Medicine and Pulmonary Drug Delivery2010578
2The Mechanism of Breath Aerosol FormationJournal of Aerosol Medicine and Pulmonary Drug Delivery2009341
3Aerosol Deposition in Health and DiseaseJournal of Aerosol Medicine and Pulmonary Drug Delivery2012297
4Update on Macrophage Clearance of Inhaled Micro- and NanoparticlesJournal of Aerosol Medicine and Pulmonary Drug Delivery2010273
5Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ TechnologyJournal of Aerosol Medicine and Pulmonary Drug Delivery2011268
6The History of Therapeutic Aerosols: A Chronological ReviewJournal of Aerosol Medicine and Pulmonary Drug Delivery2017194
7The Particle has Landed—Characterizing the Fate of Inhaled PharmaceuticalsJournal of Aerosol Medicine and Pulmonary Drug Delivery2010191
8Predictors of Incorrect Inhalation Technique in Patients with Asthma or COPD: A Study Using a Validated Videotaped Scoring MethodJournal of Aerosol Medicine and Pulmonary Drug Delivery2010181
9Role of Cilia, Mucus, and Airway Surface Liquid in Mucociliary Dysfunction: Lessons from Mouse ModelsJournal of Aerosol Medicine and Pulmonary Drug Delivery2008165
10Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD PatientsJournal of Aerosol Medicine and Pulmonary Drug Delivery2016146
11Aerosol Delivery During Mechanical Ventilation: From Basic Techniques to New DevicesJournal of Aerosol Medicine and Pulmonary Drug Delivery2008142
12Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD PatientsJournal of Aerosol Medicine and Pulmonary Drug Delivery2010139
13An Open Label, Pilot Study of Aerosurf®Combined with nCPAP to Prevent RDS in Preterm NeonatesJournal of Aerosol Medicine and Pulmonary Drug Delivery2010138
14Origin of Exhaled Breath Particles from Healthy and Human Rhinovirus-Infected SubjectsJournal of Aerosol Medicine and Pulmonary Drug Delivery2011132
15Breathing Is Enough: For the Spread of Influenza Virus and SARS-CoV-2 by Breathing OnlyJournal of Aerosol Medicine and Pulmonary Drug Delivery2020131
16In Vitro/In VivoComparisons in Pulmonary Drug DeliveryJournal of Aerosol Medicine and Pulmonary Drug Delivery2008129
17Aerosolized ChemotherapyJournal of Aerosol Medicine and Pulmonary Drug Delivery2008120
18Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray PumpJournal of Aerosol Medicine and Pulmonary Drug Delivery2012119
19Validation of a General In Vitro Approach for Prediction of Total Lung Deposition in Healthy Adults for Pharmaceutical Inhalation ProductsJournal of Aerosol Medicine and Pulmonary Drug Delivery2013113
20Measurement Techniques for Respiratory Tract Deposition of Airborne Nanoparticles: A Critical ReviewJournal of Aerosol Medicine and Pulmonary Drug Delivery2014111
21Air Pollution During Pregnancy and Neonatal Outcome: A ReviewJournal of Aerosol Medicine and Pulmonary Drug Delivery2013105
22Interindividual Variability in Nasal Filtration as a Function of Nasal Cavity GeometryJournal of Aerosol Medicine and Pulmonary Drug Delivery2009100
23Characterization of Exhaled Particles from the Healthy Human Lung—A Systematic Analysis in Relation to Pulmonary Function VariablesJournal of Aerosol Medicine and Pulmonary Drug Delivery2010100
24In VitroTests for Aerosol Deposition. I: Scaling a Physical Model of the Upper Airways to Predict Drug Deposition Variation in Normal HumansJournal of Aerosol Medicine and Pulmonary Drug Delivery201298
25Aerosol Delivery through Nasal Cannulas: An In Vitro StudyJournal of Aerosol Medicine and Pulmonary Drug Delivery200897
26Combined Determination of the Chemical Composition and of Health Effects of Secondary Organic Aerosols: The POLYSOA ProjectJournal of Aerosol Medicine and Pulmonary Drug Delivery200895
27Evaluation of the Respimat Soft Mist Inhaler using a Concurrent CFD and In Vitro ApproachJournal of Aerosol Medicine and Pulmonary Drug Delivery200995
28In Vivo–In VitroCorrelations: Predicting Pulmonary Drug Deposition from Pharmaceutical AerosolsJournal of Aerosol Medicine and Pulmonary Drug Delivery201093
29Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary ReportJournal of Aerosol Medicine and Pulmonary Drug Delivery201093
30Comparison of Deposition in the USP and Physical Mouth–Throat Models with Solid and Liquid ParticlesJournal of Aerosol Medicine and Pulmonary Drug Delivery201193
31Recent Advances in Predictive Understanding of Respiratory Tract DepositionJournal of Aerosol Medicine and Pulmonary Drug Delivery200892
32Inhalation Therapy in Patients Receiving Mechanical Ventilation: An UpdateJournal of Aerosol Medicine and Pulmonary Drug Delivery201292
33Characterization of Nebulized Liposomal Amikacin (Arikace™) as a Function of Droplet SizeJournal of Aerosol Medicine and Pulmonary Drug Delivery200891
34Pulmonary Formulations: What Remains to be Done?Journal of Aerosol Medicine and Pulmonary Drug Delivery201091
35Global Burden of Chronic Respiratory DiseasesJournal of Aerosol Medicine and Pulmonary Drug Delivery202090
36A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male VolunteersJournal of Aerosol Medicine and Pulmonary Drug Delivery200988
37Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled ProductsJournal of Aerosol Medicine and Pulmonary Drug Delivery201287
38Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder InhalersJournal of Aerosol Medicine and Pulmonary Drug Delivery201786
39Reducing Aerosol-Related Risk of Transmission in the Era of COVID-19: An Interim Guidance Endorsed by the International Society of Aerosols in MedicineJournal of Aerosol Medicine and Pulmonary Drug Delivery202085
40New Pharmacotherapy for Airway Mucus Hypersecretion in Asthma and COPD: Targeting Intracellular Signaling PathwaysJournal of Aerosol Medicine and Pulmonary Drug Delivery201084
41The Inhalation Characteristics of Patients When They Use Different Dry Powder InhalersJournal of Aerosol Medicine and Pulmonary Drug Delivery201584
42In VitroTests for Aerosol Deposition II: IVIVCs for Different Dry Powder Inhalers in Normal AdultsJournal of Aerosol Medicine and Pulmonary Drug Delivery201381
43The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow RatesJournal of Aerosol Medicine and Pulmonary Drug Delivery202081
44Aerosol Therapy in Adults Receiving High Flow Nasal Cannula Oxygen TherapyJournal of Aerosol Medicine and Pulmonary Drug Delivery201680
45Deposition MechanismsJournal of Aerosol Medicine and Pulmonary Drug Delivery202080
46Prevalence and COPD Phenotype for a Suboptimal Peak Inspiratory Flow Rate against the Simulated Resistance of the Diskus® Dry Powder InhalerJournal of Aerosol Medicine and Pulmonary Drug Delivery201379
47Influence of Particle Size and Material Properties on Mucociliary Clearance from the AirwaysJournal of Aerosol Medicine and Pulmonary Drug Delivery201078
48Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder InhalersJournal of Aerosol Medicine and Pulmonary Drug Delivery201678
49The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and CaregiversJournal of Aerosol Medicine and Pulmonary Drug Delivery201577
50Inhaled Prostanoids in the Therapy of Pulmonary HypertensionJournal of Aerosol Medicine and Pulmonary Drug Delivery200876